Adaptable immunotherapies for cancer and infectious disease
| Date | Round | Amount |
|---|---|---|
| Jan 2023 | Grant Helsinki biotech Valo Therapeutics received a EUR2.23M EIC grant for its PeptiCHIP platform. | $2.4M |
| Nov 2021 | Funding round Helsinki immuno-oncology biotech Valo Therapeutics raised a EUR 11M oversubscribed pre-IPO round led by Ironside Capital. | $11M |